Skip to main content
Premium Trial:

Request an Annual Quote

Faster Together

The US Food and Drug Administration is teaming up with medical device companies and non-profit groups to speed up the development time for medical devices, reports Nature Medicine's Spoonful of Medicine blog. To do so, the groups created the Medical Device Innovation Consortium, which FDA commissioner Margaret Hamburg said, during a press conference, would "create a safe haven for pre-competitive collaborative research between academia and industry focusing on medical devices."

MedPage Today notes that FDA has often been accused of having a "convoluted, slow, and unpredictable" device-approval process, and, consequently, devices are often first approved in Europe.

By the Medical Device Innovation Consortium members sharing resources and ideas, "for the first time, we can determine priorities, bring together collaborative minds and analyze post-market values to determine safety and efficacy," said Jeffrey Shuren, the director of FDA's Center for Devices and Radiological Health, at the press conference, according to the Spoonful of Medicine.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.